Form 4 for RGEN REPLIGEN CORP
Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-02 · accession 0000950170-24-091156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-05 | 2024-08-02 | RGEN | KURIYEL RALF | Senior VP, R, D | S - Sale+OE | $159.35 | -7,148 | 12.3K | -37% | -$1.14M |
| D | 2024-08-05 | 2024-08-02 | RGEN | KURIYEL RALF | Senior VP, R, D | M - OptEx | $86.10 | +175 | 12.5K | +1% | +$15.1K |
| D | 2024-08-05 | 2024-08-02 | RGEN | KURIYEL RALF | Senior VP, R, D | M - OptEx | $0.00 | +175 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-02 | S | D | 6,973 | $159.36 | 12,288 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-02 | M | A | 175 | $86.10 | 12,463 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-02 | S | D | 175 | $158.85 | 12,288 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-08-02 | M | A | 175 | $0.00 | 0 | D | $86.10 · — to 2030-02-27 | 175 Common Stock | (F1) This option is fully vested and exercisable. Exhibit 24.1: Power of Attorney |